Distinguished in Obstructive Sleep Apnea

Dr. James Andry

Sleep Medicine
Office
5290 Medical Dr Ste A, 
San Antonio, TX 
Offers Telehealth
Distinguished in Obstructive Sleep Apnea
Office
5290 Medical Dr Ste A, 
San Antonio, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Andry is a Sleep Medicine provider in San Antonio, Texas. Dr. Andry is rated as a Distinguished provider by MediFind in the treatment of Obstructive Sleep Apnea. His top areas of expertise are Obstructive Sleep Apnea, Narcolepsy, Excessive Daytime Sleepiness, and Drowsiness.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 3 clinical trials in the study of Obstructive Sleep Apnea.

Specialties
Sleep Medicine
Licenses
Specialist in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Office
5290 Medical Dr Ste A, San Antonio, TX 78229
Call: 210-614-6000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
Study Using Negative Pressure to Reduce Apnea (SUPRA)
Study Using Negative Pressure to Reduce Apnea (SUPRA)
Enrollment Status: Active_not_recruiting
Publish Date: April 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Device
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)
Enrollment Status: Completed
Publish Date: September 21, 2018
Intervention Type: Other
View 12 Less Clinical Trials

3 Total Publications

Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial.
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial.
Journal: Annals of the American Thoracic Society
Published: May 01, 2020
View All 3 Publications
Similar Doctors
Distinguished in Obstructive Sleep Apnea
Dr. Kathleen R. Wilson
Sleep Medicine
Distinguished in Obstructive Sleep Apnea
Dr. Kathleen R. Wilson
Sleep Medicine

Kathy Wilson, M.D., P. A.

703 Hill Country Dr, Suite 302, 
Kerrville, TX 
 (49.9 miles away)
830-792-1132
Languages Spoken:
English
See accepted insurances

Kathleen Wilson is a Sleep Medicine provider in Kerrville, Texas. Dr. Wilson is rated as an Advanced provider by MediFind in the treatment of Obstructive Sleep Apnea. Her top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Periodic Limb Movement Disorder, and Drowsiness.

Distinguished in Obstructive Sleep Apnea
Dr. Avie A. Grunspan
Sleep Medicine
Distinguished in Obstructive Sleep Apnea
Dr. Avie A. Grunspan
Sleep Medicine
4114 Pond Hill Road, Suite 101, 
San Antonio, TX 
 (6.3 miles away)
210-249-5020
Languages Spoken:
English, Hebrew, Spanish, Yiddish
See accepted insurances
Accepting New Patients

Avie Grunspan is a Sleep Medicine provider in San Antonio, Texas. Dr. Grunspan is rated as an Advanced provider by MediFind in the treatment of Obstructive Sleep Apnea. His top areas of expertise are Obstructive Sleep Apnea, Restless Legs Syndrome, Insomnia, and Drowsiness. Dr. Grunspan is currently accepting new patients.

Distinguished in Obstructive Sleep Apnea
Dr. Shakil A. Khan
Sleep Medicine
Distinguished in Obstructive Sleep Apnea
Dr. Shakil A. Khan
Sleep Medicine

Community Medicine Associates

903 W Martin St, Ms 49 2, 
San Antonio, TX 
 (7.6 miles away)
210-358-3441
Languages Spoken:
English, Arabic, Urdu
See accepted insurances
Accepting New Patients

Shakil Khan is a Sleep Medicine provider in San Antonio, Texas. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Obstructive Sleep Apnea. His top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Insomnia, and Excessive Daytime Sleepiness. Dr. Khan is currently accepting new patients.

VIEW MORE OBSTRUCTIVE SLEEP APNEA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Andry's expertise for a condition
ConditionClose
    • Distinguished
    • Drowsiness
      Dr. Andry is
      Distinguished
      . Learn about Drowsiness.
      See more Drowsiness experts
    • Excessive Daytime Sleepiness
      Dr. Andry is
      Distinguished
      . Learn about Excessive Daytime Sleepiness.
      See more Excessive Daytime Sleepiness experts
    • Narcolepsy
      Dr. Andry is
      Distinguished
      . Learn about Narcolepsy.
      See more Narcolepsy experts
    • Obstructive Sleep Apnea
      Dr. Andry is
      Distinguished
      . Learn about Obstructive Sleep Apnea.
      See more Obstructive Sleep Apnea experts
    • Advanced
    • Asthma
      Dr. Andry is
      Advanced
      . Learn about Asthma.
      See more Asthma experts
    • Asthma in Children
      Dr. Andry is
      Advanced
      . Learn about Asthma in Children.
      See more Asthma in Children experts
    • Central Sleep Apnea
      Dr. Andry is
      Advanced
      . Learn about Central Sleep Apnea.
      See more Central Sleep Apnea experts
    • Idiopathic Hypersomnia
      Dr. Andry is
      Advanced
      . Learn about Idiopathic Hypersomnia.
      See more Idiopathic Hypersomnia experts
    • Insomnia
      Dr. Andry is
      Advanced
      . Learn about Insomnia.
      See more Insomnia experts
    • Irregular Sleep-Wake Syndrome
      Dr. Andry is
      Advanced
      . Learn about Irregular Sleep-Wake Syndrome.
      See more Irregular Sleep-Wake Syndrome experts
    View All 9 Advanced Conditions
    • Experienced
    • Chronic Obstructive Pulmonary Disease (COPD)
      Dr. Andry is
      Experienced
      . Learn about Chronic Obstructive Pulmonary Disease (COPD).
      See more Chronic Obstructive Pulmonary Disease (COPD) experts
    • Empyema
      Dr. Andry is
      Experienced
      . Learn about Empyema.
      See more Empyema experts
    • Grass Allergy
      Dr. Andry is
      Experienced
      . Learn about Grass Allergy.
      See more Grass Allergy experts
    • Hyperventilation
      Dr. Andry is
      Experienced
      . Learn about Hyperventilation.
      See more Hyperventilation experts
    • Lung Metastases
      Dr. Andry is
      Experienced
      . Learn about Lung Metastases.
      See more Lung Metastases experts
    • Periodic Limb Movement Disorder
      Dr. Andry is
      Experienced
      . Learn about Periodic Limb Movement Disorder.
      See more Periodic Limb Movement Disorder experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.